| 规格 | 10ug |
|---|---|
| 表达宿主 | E.coli |
| 标签 | NA |
| 分子量 | 11.4 KDa |
|---|---|
| 表观分子量 | 16 KDa, reducing conditions |
| 形态 | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
| 纯度 | Greater than 95% as determined by reducing SDS-PAGE. |
| 内毒素水平 | Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. |
|---|
| 溶解方法 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|---|
| 储存方法 | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
| 背景说明 | Amphiregulin (AREG) is a single-pass membrane protein with 252 amino acids. AREG belongs to the amphiregulin family, which contains 1 EGF-like domain. AREG is expressed in a variety of tissues including ovary, placenta, lung, kidney, stomach, colon, and breast. It is related to Epidermal Growth Factor (EGF) and Transforming Growth Factor Alpha (TGF-alpha). As an EGF-related growth factor, AREG interacts with the EGF/TGF-alpha receptor to promote the growth of normal epithelial cells and inhibits the growth of certain aggressive carcinoma cell lines. AREG may also play a protective role in Bleomycin-Induced Pneumopathy. |
|---|
| 产品名称 | 点击数 |
|---|---|
| HDV 丁肝 | 1721 |
| 伤寒抗原 | 1517 |
| Syphilis 梅毒抗原抗体 | 1591 |
| A型产气荚膜梭菌a毒素蛋白 | 1528 |
| Clonorchiasis 肝吸虫 | 1354 |
| Schistosoma 血吸虫 | 1398 |
| β内酰胺受体 | 1351 |
| cProg犬孕酮 | 1469 |
| 犬钩端螺旋体抗原 | 1960 |
| 弓形虫抗原 | 1969 |
| FHV-I猫疱疹I型抗原 | 2146 |
| FIV猫艾滋抗原 | 2087 |
| 包虫 | 2208 |
| 犬瘟热重组抗原 Canine Distemper Virus Antigen | 1152 |
| Recombinant Human IGFBP-5 (C-6His) | 403 |
| Recombinant 2019-nCoV NSP10 (N-6His) | 383 |
| Recombinant 2019-nCoV Guanine-N7_meth (N-6His) | 446 |
| Recombinant Human EGF | 836 |
| Recombinant Human TGF-beta 1 | 852 |
| Anti-2019-nCoV S-IgM Neutralizing Antibody (8A5) | 658 |